Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to pharmaceutical distribution (SUPPORT for Patients and Communities Reauthorization Act of 2025, H.R. 2483 / S. 2121).
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
LYKOS THERAPEUTICS via LYKOS THERAPEUTICS
2025 · second_quarter · 2T
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); issues related to therapeutics and implementation research and development (Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, H.R. 3944 / no Senate bill number).
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); issues related to therapeutics and implementation research and development (Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, H.R. 3944 / no Senate bill number).
Source: Senate LDA
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); issues related to therapeutics and implementation research and development (Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, H.R. 3944 / no Senate bill number).
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); issues related to therapeutics and implementation research and development (Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, H.R. 3944 / no Senate bill number).
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); issues related to therapeutics and implementation research and development (Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, H.R. 3944 / no Senate bill number).
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to pharmaceutical distribution (SUPPORT for Patients and Communities Reauthorization Act of 2025, H.R. 2483 / S. 2121).
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics and implementation research and development).
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics and implementation research and development).
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics and implementation research and development).
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
Support for Patients and Communities Reauthorization Act
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act (issues related to pharmaceutical distribution).
Support for Patients and Communities Reauthorization Act
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act (provisions related to pharmaceutical distribution).
Support for Patients and Communities Reauthorization Act
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act (issues related to pharmaceutical distribution).
Support for Patients and Communities Reauthorization Act
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act (issues related to pharmaceutical distribution).
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics and implementation research and development).
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics and implementation research and development).
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics and implementation research and development).
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
SUPPORT for Patients and Communities Reauthorization Act
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act (issues related to pharmaceutical distribution).
SUPPORT for Patients and Communities Reauthorization Act
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act (issues related to pharmaceutical distribution).
SUPPORT for Patients and Communities Reauthorization Act
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act (provisions related to pharmaceutical distribution).
SUPPORT for Patients and Communities Reauthorization Act
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act (issues related to pharmaceutical distribution).
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development. H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act, regarding issues related to pharmaceutical distribution.
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Support for Patients and Communities Reauthorization Act
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development. H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act, regarding issues related to pharmaceutical distribution.
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development. H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act, regarding issues related to pharmaceutical distribution.
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
SUPPORT for Patients and Communities Reauthorization Act
Client: LYKOS THERAPEUTICS · Firm: LYKOS THERAPEUTICS
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development. H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act, regarding issues related to pharmaceutical distribution.
Issues related to pharmaceutical distribution (SUPPORT for Patients and Communities Reauthorization Act of 2025, H.R. 2483 / S. 2121).
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); issues related to therapeutics and implementation research and development (Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, H.R. 3944 / no Senate bill number).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LYKOS THERAPEUTICS via LYKOS THERAPEUTICS
2025 · first_quarter · Q1
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating innovative mental health challenges, including PTSD (no bill); Fiscal Year 2026 Military Construction, Veterans Affairs and Related Agencies Appropriations Act (issues related to therapeutics and implementation research and development) (no bill number).
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating innovative mental health challenges, including PTSD (no bill); Fiscal Year 2026 Military Construction, Veterans Affairs and Related Agencies Appropriations Act (issues related to therapeutics and implementation research and development) (no bill number).
Fiscal Year 2026 Commerce, Justice, Science and Related Agencies Appropriations Act (issues related to potential improvements to Food & Drug Administration and Drug Enforcement Administration processes for rescheduling of controlled substances) (no bill number).
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating innovative mental health challenges, including PTSD (no bill); Fiscal Year 2026 Military Construction, Veterans Affairs and Related Agencies Appropriations Act (issues related to therapeutics and implementation research and development) (no bill number).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LYKOS THERAPEUTICS via LYKOS THERAPEUTICS
2024 · fourth_quarter · Q4
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics and implementation research and development).
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics and implementation research and development).
H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act (provisions related to pharmaceutical distribution).
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics and implementation research and development).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LYKOS THERAPEUTICS via LYKOS THERAPEUTICS
2024 · third_quarter · Q3
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act (issues related to pharmaceutical distribution).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LYKOS THERAPEUTICS via LYKOS THERAPEUTICS
2024 · second_quarter · Q2
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act (issues related to pharmaceutical distribution).
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (issues related to therapeutics research and development).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
LYKOS THERAPEUTICS via LYKOS THERAPEUTICS
2024 · first_quarter · Q1
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act (issues related to pharmaceutical distribution).
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
LYKOS THERAPEUTICS via LYKOS THERAPEUTICS
2023 · fourth_quarter · Q4
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development. H.R. 4531 / S. 3393, Support for Patients and Communities Reauthorization Act, regarding issues related to pharmaceutical distribution.
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
LYKOS THERAPEUTICS via LYKOS THERAPEUTICS
2023 · third_quarter · Q3
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
LYKOS THERAPEUTICS via LYKOS THERAPEUTICS
2023 · second_quarter · Q2
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill).
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill).
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill).
LYKOS THERAPEUTICS via LYKOS THERAPEUTICS
2023 · first_quarter · Q1
Issues related to MDMA assisted therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill).
Issues related to MDMA assisted therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill).
Issues related to MDMA assisted therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill).
LYKOS THERAPEUTICS via LYKOS THERAPEUTICS
2022 · fourth_quarter · RR
Issues related to funding for veterans mental health treatment; issues related to funding for Post-traumatic stress disorder treatment; issues related to mental health treatment access.
Issues related to funding for veterans mental health treatment; issues related to funding for Post-traumatic stress disorder treatment; issues related to mental health treatment access.
Issues related to funding for veterans mental health treatment; issues related to funding for Post-traumatic stress disorder treatment; issues related to mental health treatment access.
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill); H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD. H.R. 4366 / S. 2127, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, regarding therapeutics research and development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to MDMA Assisted Therapy research, education and capacity building to support potential for treating mental health challenges, including PTSD (no bill).
Filing targets: HOUSE OF REPRESENTATIVES, Veterans Affairs, Dept of (VA)
Issues related to MDMA assisted therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to funding for veterans mental health treatment; issues related to funding for Post-traumatic stress disorder treatment; issues related to mental health treatment access.